全文获取类型
收费全文 | 41621篇 |
免费 | 3148篇 |
国内免费 | 1328篇 |
专业分类
耳鼻咽喉 | 80篇 |
儿科学 | 670篇 |
妇产科学 | 349篇 |
基础医学 | 6108篇 |
口腔科学 | 390篇 |
临床医学 | 3631篇 |
内科学 | 6082篇 |
皮肤病学 | 712篇 |
神经病学 | 2945篇 |
特种医学 | 611篇 |
外国民族医学 | 4篇 |
外科学 | 2073篇 |
综合类 | 5583篇 |
现状与发展 | 5篇 |
一般理论 | 3篇 |
预防医学 | 2747篇 |
眼科学 | 303篇 |
药学 | 10229篇 |
14篇 | |
中国医学 | 1482篇 |
肿瘤学 | 2076篇 |
出版年
2023年 | 552篇 |
2022年 | 755篇 |
2021年 | 1308篇 |
2020年 | 1229篇 |
2019年 | 1319篇 |
2018年 | 1298篇 |
2017年 | 1375篇 |
2016年 | 1311篇 |
2015年 | 1337篇 |
2014年 | 2406篇 |
2013年 | 3581篇 |
2012年 | 2277篇 |
2011年 | 2485篇 |
2010年 | 1913篇 |
2009年 | 1743篇 |
2008年 | 1695篇 |
2007年 | 1825篇 |
2006年 | 1565篇 |
2005年 | 1500篇 |
2004年 | 1329篇 |
2003年 | 1280篇 |
2002年 | 999篇 |
2001年 | 935篇 |
2000年 | 841篇 |
1999年 | 678篇 |
1998年 | 631篇 |
1997年 | 655篇 |
1996年 | 590篇 |
1995年 | 701篇 |
1994年 | 628篇 |
1993年 | 618篇 |
1992年 | 595篇 |
1991年 | 536篇 |
1990年 | 466篇 |
1989年 | 341篇 |
1988年 | 368篇 |
1987年 | 279篇 |
1986年 | 249篇 |
1985年 | 443篇 |
1984年 | 320篇 |
1983年 | 226篇 |
1982年 | 186篇 |
1981年 | 129篇 |
1980年 | 106篇 |
1979年 | 87篇 |
1978年 | 94篇 |
1977年 | 69篇 |
1976年 | 56篇 |
1975年 | 49篇 |
1974年 | 32篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
21.
BackgroundNational Comprehensive Cancer Network (NCCN) guidelines can include recommendations for off-label use of anti-cancer drugs. Here, we evaluate NCCN recommendations not supported by US Food and Drug Administration (FDA) approval and explore associations with such recommendations.MethodsAll NCCN recommendations for MBC and their supporting data were identified. Drug labels were reviewed to determine whether recommendations are FDA approved. Logistic regression was used to compare FDA approved and off-label recommendations for pre-specified categories, including drug type, tumor subtype, level of recommendation and line of therapy.ResultsOf 124 recommendations identified, 68 (55%) were off-label. Chemotherapy and human epidermal growth factor receptor 2 (HER2) targeted drugs were associated with lower odds of FDA approval (OR = 0.28, p = 0.001 and OR = 0.29, 95% p = 0.005, respectively). Recommendations for endocrine therapy (OR = 3.44, p = 0.009) and non-HER2 targeted treatment (OR = 10.0, p < 0.001) were more commonly FDA approved indications. Compared to combination therapies, monotherapies were more likely to be FDA approved (OR = 3.45, p = 0.001) as were category 1 (OR = 7.63, p = 0.001) and preferred NCCN recommendations (OR = 4.07, p < 0.001). Compared to off-label recommendations, NCCN recommendations of approved drugs were based on significantly higher sample size (mean 477 vs. 342 patients, p = 0.02) and were non-significantly associated with availability of randomized data (OR = 2.0, 95% CI 0.89–4.49, p = 0.09).ConclusionMore than half of all NCCN recommendations for MBC are off-label, mostly involving chemotherapy containing regimes for HER2 negative disease and combinations which include HER2-targeted drugs. Improved transparency of NCCN guidelines may result from reporting of the strength of the evidence supporting recommendations for MBC. 相似文献
22.
23.
Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in Western countries and is characterized by the clonal expansion of mature CD5+ B cells. There have been substantial advances in the field of CLL research in the last decade, including the identification of recurrent mutations, and clarification of clonal architectures, signaling molecules, and the multistep leukemogenic process, providing a comprehensive understanding of CLL pathogenesis. Furthermore, the development of therapeutic approaches, especially that of molecular target therapies against CLL, has markedly improved the standard of care for CLL. This review focuses on the recent insights made in CLL leukemogenesis and the development of novel therapeutic strategies. 相似文献
24.
邹华兰 《中国继续医学教育》2020,(10):106-108
目的 探讨对气管支气管结核患者选择经支气管镜介入+抗结核药物治疗后获得的临床效果.方法 选择医院2017年3月—2019年4月收治的78例气管支气管结核患者作为试验对象;数字奇偶法分组后探究每组治疗方法;比照组(39例):选择抗结核药物展开疾病治疗;试验组(39例):选择经支气管镜介入+抗结核药物展开疾病治疗;最终就组间气管支气管结核组间治疗结果 差异展开对比.结果 试验组气管支气管结核患者治疗总有效率(97.44%)高于比照组(74.36%)明显(P<0.05).结论 气管支气管结核患者于临床接受经支气管镜介入+抗结核药物治疗后,利于结核疗效提升,可促进气管支气管结核患者康复进程缩短. 相似文献
25.
Simran Khanijo Rohit Kumar Amol Narayan Patil Gomata Bhusal Gopal Vishwas 《Expert review of clinical pharmacology》2020,13(7):797-806
ABSTRACT
Background
With the goal of improving the affordability of medicines, governments across the globe have instituted various forms of price controls. Since 2013, India has been regulating the prices of drugs included in its national list of essential medicines (NLEM). Here we evaluate the cost variations among available cardiovascular drugs and perform cost-analysis comparing essential and non-essential drugs. 相似文献26.
Objectives
We explored levonorgestrel (LNG) concentrations, bleeding patterns and endometrial thickness in women with epilepsy (WWE) initiating an LNG-intrauterine device (IUD) co-administered with antiepileptic drugs (AEDs).Study design
This pilot study included 20 WWE ages 18 to 45 years with well-controlled seizures and stable AED regimens initiating a 52-mg LNG-IUD (20 mcg/d initial release). We collected blood and measured endometrial thickness before IUD placement and 21 days, 3 months and 6 months thereafter. Participants recorded bleeding/spotting daily. We measured total LNG (radioimmunoassay), serum hormone binding globulin (SHBG, immunoassay) and calculated the free LNG index. We compared total LNG, free LNG index, SHBG and endometrial thickness over time using a linear mixed-effects model.Results
Total LNG, free LNG index and SBHG levels remained stable from day 21 throughout. Endometrial thickness decreased from a median of 5.9 mm [interquartile range (IQR) 4.6–7.5] at day 21 to 3.3mm (2.8–4.9) by month 6 (p=0.02). Bleeding and spotting days decreased from a median of 16 (IQR 13–23) in month 1 to 6.5 (IQR 4–8.5) in month 6 regardless of AED regimen.Conclusion
Like women without epilepsy, WWE initiating the LNG-IUD experience stable total LNG concentrations and decreasing endometrial thickness and bleeding over the first 6 months of use.Implications
Like women without epilepsy, WWE using antiepileptic drugs can expect a stable LNG concentration and decreasing bleeding during the first 6 months of LNG-IUD use. Our data can be useful for guidance of WWE considering use the LNG-IUD. 相似文献27.
28.
N. Shor R. Deschamps A. Cobo Calvo E. Maillart H. Zephir J. Ciron C. Papeix F. Durand-Dubief A. Ruet X. Ayrignac M. Cohen K. Deiva D. Laplaud B. Bourre B. Audoin N. Collongues S. Vukusic F. Cotton R. Marignier 《Revue neurologique》2021,177(1-2):39-50
Our knowledge of the radiological spectrum of myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD) is growing rapidly. An update on the radiological features of the disease, and its evolution is thus necessary. Magnetic resonance imaging (MRI) has an increasingly important role in the differential diagnosis of MOGAD particularly from aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD), and multiple sclerosis (MS). Differentiating these conditions is of prime importance because the management is different between the three inflammatory diseases, and thus could prevent further attack-related disability. Therefore, identifying the MRI features suggestive of MOGAD has diagnostic and prognostic implications. We herein review optic nerve, spinal cord and the brain MRI findings from MOGAD adult patients, and compare them to AQP4-NMOSD and MS. 相似文献
29.
30.